Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

PK and Safety of Paclitaxel Injection Concentrate for Nano-dispersion Alone and in Carboplatin Combination

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2013 by Sun Pharma Advanced Research Company Limited
Sponsor:
Information provided by (Responsible Party):
Sun Pharma Advanced Research Company Limited
ClinicalTrials.gov Identifier:
NCT01304303
First received: February 23, 2011
Last updated: January 18, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2013
  Estimated Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)